Neobiosis Revenue and Competitors
Estimated Revenue & Valuation
- Neobiosis's estimated annual revenue is currently $1.9M per year.
- Neobiosis's estimated revenue per employee is $155,000
Employee Data
- Neobiosis has 12 Employees.
- Neobiosis grew their employee count by -40% last year.
Neobiosis's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
2 | Director Strategic Development | Reveal Email/Phone |
3 | Director Administration | Reveal Email/Phone |
4 | Key Partner Development Manager | Reveal Email/Phone |
5 | Legal Liaison | Reveal Email/Phone |
Neobiosis Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $15.3M | 99 | 5% | N/A | N/A |
#2 | $1.1M | 7 | -30% | N/A | N/A |
#3 | $3.7M | 24 | 4% | N/A | N/A |
#4 | $4.3M | 28 | -3% | N/A | N/A |
#5 | $2.5M | 16 | N/A | N/A | N/A |
#6 | $0.8M | 5 | 0% | N/A | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $2.5M | 16 | 7% | N/A | N/A |
#9 | $1.4M | 9 | -25% | N/A | N/A |
#10 | $0.6M | 4 | 0% | N/A | N/A |
What Is Neobiosis?
Neobiosis, LLC is a privately owned biomedical contract development and manufacturing organization (CDMO) with two production facilities in downtown Gainesville and a Research & Development laboratory located within the Sid Martin UF Innovate biotechnology Institute in Alachua, FL. The focus of Neobiosis is the isolation of tissues, cells and extracellular vesicles (EVs), with medicinal potential, from donated perinatal (birth) tissues, including umbilical cord, umbilical cord blood and amniotic fluid. The name Neobiosis ("new life") is derived from a series of experiments called Parabiosis ("living together") where it was discovered that tissues, cells and EVs from a young donor could be used to promote the healing of older individuals. Neobiosis produces innovative products from healthy, full-term births, for client organizations who wish to take biomedical products though FDA-approved clinical trials for commercialization in a global market. Neobiosis is also committed to advancing an in-house pipeline of intellectual property and biological medicines.
keywords:N/AN/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
-40%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.7M | 12 | -14% | N/A |
#2 | $1.8M | 12 | 9% | N/A |
#3 | $1M | 12 | -14% | N/A |
#4 | N/A | 12 | -8% | N/A |
#5 | $2M | 13 | 0% | N/A |